Description
CJC-1295 with DAC (Drug Affinity Complex) is a modified growth hormone-releasing hormone (GHRH) analogue. The DAC portion binds reversibly to serum albumin, which is what gives this variant its defining feature in research: a circulating half-life measured in days rather than the minutes typical of unmodified GHRH fragments.
Because of that extended half-life, CJC-1295 with DAC is the variant researchers reach for when studying sustained, low-amplitude GH pulsatility over multi-day windows, as opposed to the short, sharp GH pulses produced by DAC-free GHRH analogues or GHRP-class secretagogues.
After you place your order, a licensed physician will speak with you directly on a live call to review your health history and confirm a prescription is medically appropriate before anything ships. If your order isn’t approved, our team will contact you directly instead of shipping it. Reconstitute with bacteriostatic water, store refrigerated and protected from light.
